Harrow Raises $50M in Senior Unsecured Notes, Expanding 2030 Debt
Event summary
- Harrow priced a $50M offering of 8.625% senior unsecured notes due 2030, closing expected March 27, 2026.
- Notes are additional to $250M of existing 2030 notes issued September 12, 2025, with identical terms except issuance date and price.
- Proceeds will fund general corporate purposes, including growth initiatives, product development, and strategic opportunities.
- Offering is private, targeting qualified institutional buyers under Rule 144A and non-U.S. persons under Regulation S.
The big picture
Harrow's $50M debt raise follows a $250M issuance last year, suggesting aggressive expansion plans in the ophthalmic disease management space. The move comes amid rising interest rates, raising questions about the sustainability of high-cost debt in a capital-intensive sector. The private placement structure indicates a targeted approach to institutional investors, bypassing broader market volatility.
What we're watching
- Debt Utilization
- How Harrow allocates the $50M proceeds will signal strategic priorities, particularly in product development and M&A.
- Market Conditions
- Whether current market conditions allow Harrow to refinance or restructure existing debt at more favorable terms.
- Execution Risk
- The pace at which Harrow can deliver on growth initiatives funded by this debt issuance, given the 8.625% interest rate burden.
Related topics